Towfiqu Barbhuiya
A recent ABC News article noted that the FDA has granted approval for the first-ever alopecia treatment for children. The medication, called ritlecitinib and marketed as Litfulo by Pfizer, is a once-daily pill designed for children aged 12 and older with severe alopecia areata, a condition characterized by hair loss due to the body attacking its own hair follicles. Though the treatment costs nearly $50k/year, Pfizer says the actual cost to patients will vary based on individual healthcare plans, and the company plans to offer copay savings and a patient assistance program.
